No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Artiva Biotherapeutics Reports Q3 2024 Financial Results
Needham Maintains Artiva Biotherapeutics(ARTV.US) With Buy Rating, Maintains Target Price $23
Artiva Biotherapeutics, Inc.: Strong Buy Rating Supported by Robust Autoimmune Pipeline and Financial Stability
TD Cowen Maintains Artiva Biotherapeutics(ARTV.US) With Buy Rating
Artiva Biotherapeutics, Inc. (ARTV) Receives a Buy From TD Cowen
Artiva Biotherapeutics Q3 EPS $(0.92) Misses $(0.91) Estimate
Unlock the Full List